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Abstract One of the most fascinating aspects of the field of
epigenetics is the emerging ability of environmental factors
to trigger epigenetic changes in eukaryotic cells, thus con-
tributing to transient or stable, and potentially heritable,
changes in gene expression program in the absence of
alteration in DNA sequence. Epigenetic response may result
in cell adaptation to environmental stimuli or, in some
instances, may contribute to generation or progression of
different kind of diseases. A paradigmatic case of disease
that is accompanied by multiple epigenetic alterations is
gastric cancer, among other relevant examples. In turn,
Helicobacter pylori (Hp) infection has been associated as a
leading cause of gastric cancer. One possible hypothesis is
that Hp–gastric cell interaction initiates an epigenetic
reprogramming of host cell genome that may favor tumori-
genesis. Accordingly, an abundance of experimental evi-
dence indicates that several epigenetic alterations underlie
the gastric cancerogenesis process and that these alterations
represent one of the major hallmarks of gastric cancer.
However, several critical questions remain unanswered:
Does Hp directly provoke epigenetic alterations? Which
mechanisms underlie these phenomena? Based on currently
available data, it is often arduous to discriminate between the
epigenetic modifications directly triggered by Hp–gastric
cell interaction and those alterations that are mediated by
inflammation process or by many other molecular and
genetic events occurring during the gastric cancer progres-
sion. We will review our present knowledge of epigenetic
modifications and alterations proven to occur in host cells as
a direct consequence of Hp infection.
Keywords Helicobacter pylori–gastric cell interaction 
Epigenetic alterations  Gastric cancerogenesis  DNA
methylation  Chromatin modifications
Epigenetic modifications
Epigenetic mechanisms may operate at gene-specific level
and include both chromatin modifications, orchestrated by
chromatin-remodeling complexes and histone-modifying
enzymes, and DNA methylation, directed by DNA methyl-
transferases. Histone acetylation is in general associated
with an active state of the chromatin, while the effects of
histone methylation may be associated with either tran-
scriptional activation or repression, depending on which
lysyl residue is modified [1, 2] and whether this residue is
mono, di or trimethylated. Among the best studied H3 lysine
modifications are di- and trimethylation of H3 on lysine 9
and lysine 27 (H3K9me2 and H3K27me3), associated with
closed chromatin, and dimethylation of H3 on lysine 4
(H3K4me2) that marks active chromatin state. Cellular
stimuli may be integrated through signal transduction
pathways leading to activation of histone-modifying
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enzymes acting at gene-specific level. Among such mech-
anisms, the most widely studied is the mitogen-activated
protein kinase (MAPK) cascade which upon activation
leads to phosphorylation of histone H3 on serine 10
(H3S10). This is a mark of transcriptional activation since it
predisposes to histone acetylation [2]. DNA methylation of
CpG sites at gene regulatory regions is mostly related to
transcriptional repression. This is believed to be a more
stable epigenetic mark than histone modifications [3–5]. In
fact, DNA methylation profiles are sculpted during devel-
opment, establishing the cell-specific gene expression pro-
gram; the established DNA methylation profiles are then
believed to be quite stable during the adult life, with some
exceptions related to environmental stimuli or diseases
[6, 7]. Maintenance of properly established DNA methyl-
ation profiles is essential for mammalian development and
for the normal functioning of the adult organism. DNA
methylation is a potent mechanism for silencing gene
expression and maintaining genome stability, especially
considering the large amount of repetitive DNA sequences
which can otherwise mediate illegitimate recombination
events and cause transcriptional deregulation of neighbor-
ing genes. Chromatin modifications and DNA methylation
are strictly linked and can associate or interfere with each
other during the course of life [4, 8]. It is worth noticing that
other epigenetic marks, including 5-hydroxymethylcyto-
sine, have been recently recognized and their biological
significance is currently under deep investigation [9]. The
involvement of microRNAs (miRNAs), short RNA mole-
cules that play a role in post-transcriptional silencing of
multiple target genes, has been widely documented in
gastric cancer and Hp infection (reviewed in [10, 11]). The
role of miRNA in response to Hp infection will be not
addressed in this review.
Helicobacter pylori, inflammation, gastric cancer
and epigenetic modifications
Helicobacter pylori (Hp) is a Gram-negative, spiral-shaped
microaerophilic bacterium that is involved in several gas-
tric diseases. Individuals infected by Hp develop gastritis,
and up to 10 % of infected individuals develop duodenal
ulcer disease [12]. Persistent infection with Hp may cause
chronic atrophic gastritis, with the development of intes-
tinal metaplasia, dysplasia and gastric carcinoma [13–18].
A lot of information about this carcinogenesis pathway has
been acquired by experiments in animal models [18, 19],
and in 1994, the International Agency for Research on
Cancer classified Hp as a carcinogenic agent class I [20].
The mechanism of Hp pathogenicity is not well under-
stood. Both bacterial virulence and host susceptibility factors
have been associated with the development of chronic gastric
inflammation and gastric carcinogenesis [18–23]. VacA is a
major virulence factor of Hp and has pleiotropic effects in
target host cells. H. pylori strains containing a cluster of
approximately 30 genes known as the ‘cag’ pathogenicity
island (cagPAI) are more frequently associated with severe
gastric inflammation, ulceration and an increased risk of
gastric cancer. The intracellular protein Nod1 is a major
pathogen-recognition molecule involved in epithelial cell
sensing of cagPAI-positive H. pylori strains [24, 25]. In
addition, activation of the pattern recognition receptors TLR2,
TLR9, Rig-I and, to a lesser extent, TLR4, by H. pylori,
leading to proinflammatory signaling, has been reported [25].
Other effects induced by Hp involve bacterial components
such as HP0175 [26], presumed TLR4 ligand, or adhesins
BabA and OipA, which directly interact with host tissues [27,
28]. These virulence factors may activate multiple intracel-
lular pathways in epithelial cells such as MAPK, NF-jb, Wnt/
b-catenin, PI3K pathways, signal transducers and activators of
trascription, such as STAT3, and may alter cellular function
and/or trigger inflammatory processes. [29–32].
During the inflammation process, the Helicobacter
pylori itself as well as intrinsic mediators of inflammatory
responses, such as proinflammatory cytokines and reactive
oxygen species, can induce genetic and epigenetic changes.
These molecular events combine to alter important path-
ways involved in normal cellular function, thereby accel-
erating inflammation-associated cancer development.
Epigenetic alterations have been suggested to play a key
role early in gastric tumorigenesis. There is plenty of
experimental evidence linking Helicobacter infection to
aberrant epigenetic signatures of gastric cells observed
during gastric cancerogenesis [33–36]. However, it is rea-
sonable to believe that most of the epigenetic modifications
observed in gastric tumors might have been established in
any phase of the carcinogenesis process including Hp–
gastric cell interaction, early inflammatory response to
infection, chronic inflammation and cancer progression. In
this review, we will first summarize evidences of epigenetic
modification generally related to Hp infection in human
tumors and animal models. We will then review advances
obtained in recent works by experimental models consisting
in cultured cells in the presence or absence of Hp or Hp
extracts, in which any epigenetic modification observed in
host cells may be bona fide attributed to, or demonstrated to
be, a consequence of a signaling cascade triggered by the
direct interaction of Hp components with host cell and not
by indirect signaling, for example, via cytokines produced
by other sources within the infected tissue.
Gene-specific DNA methylation alteration
An early observation was that E-cadherin gene (CDH1)
underwent hypermethylation in Hp-infected normal gastric
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mucosa compared to non-infected individuals [37, 38].
Then, Hp-related altered DNA methylation state of several
other genes, including those related to cell growth control,
(p16, p14 and APC), DNA repair (hMLH, BRCA1,
MGMT) and cell adhesion (CDH1), has been described
[39–51]. A list of some representative ones is presented in
Table 1. By studying 48 promoter CpG islands using
methylation-specific PCR, Nakajima et al. [52] found that
26 genes were consistently hypermethylated in individuals
with current or past Hp infection. In addition to several
markers associated with protein coding genes, CpG islands
within microRNA genes were found hypermethylated in
the presence of Hp infection (reviewed in [10, 11]).
Global epigenetic alteration
Epigenetic alterations at global level were also associated
with Hp-related gastric cancer [53–57] most of which are
listed in Table 2. Park et al. [53] found that the high global
levels of H3K9me3, and not H3K9 acetylation, correlated
with tumor stage, lymphovascular invasion, cancer recur-
rence and thus with poor survival rate. In another study,
Weichert et al. [54] found that the expression levels of
HDAC isoforms 1, 2 and 3 correlate with poor prognosis.
Thus, the authors suggested that HDACs expression may
be considered a prognostic marker and a potential target
of epigenetic therapy for gastric cancer. Furthermore,
Takahashi et al. [55] by investigating 122 patients observed
that overexpression of phospho-H3S10 correlated with
poor prognosis for gastric cancer.
Gene-specific chromatin alteration
Chromatin alterations were found in Hp-related gastric
cancer also at gene-specific level (Table 3). Hypoacetyla-
tion of histones H3 and H4, associated with CpG hyper-
methylation, was found at the tumor suppressor genes
HLTF [58], p21(WAF1/CIP1) [59, 60] and SLC5A8 [61] in
Hp-related gastric cancer.
Epigenetic modifications after Hp infection eradication
Animal models were very useful to study the dynamic of
epigenetic changes during Hp infections. Mongolian ger-
bils experimentally infected with Helicobater pylori
exhibited hypermethylation at several promoters from the
gastric mucosa [62, 63]. Methylation levels increased
during the first weeks after infection and, although
remaining higher than in uninfected animals, decreased
significantly some weeks after eradication of infection.
Other interesting studies [44, 64] evaluated promoter
methylation of CDH1 and other genes related to gastric
carcinogenesis (p16, APC, MLH1 and COX2) in patients
with active or eradicated Hp infection. Perri et al. [64]
found that while CDH1 methylation was an early event in
Hp gastritis, MLH1 methylation occurred late along with
intestinal metaplasia, and that Hp eradication was able to
significantly reduce gene methylation, thus delaying or
reversing Hp-induced gastric carcinogenesis [64].
Epigenetic changes and gastric inflammation
It appears very likely that many epigenetic changes in Hp-
infected tissues may be mediated by the inflammation
process. The inflammatory molecules TNFa, IL-1b and
NOS2 have been considered as the main mediators of a
Table 1 Genes differentially methylated in relation to gastric Hp
infection
Genes Major functions Reference
p16
(INK4a)
CDK inhibitor 35
p14 (ARF) MDM2 inhibitor 35
APC Cell adhesion regulator 41
hMLH1 DNA mismatch repair 36
BRCA1 DNA repair 42
MGMT DNA repair 43
E-cadherin Calcium-dependent adhesion 44
LOX Lysyl oxidase 45
FLNc Muscle-specific filamin 46
HRASLS HRAS-like suppressor 46
HAND1 Heart- and neural crest derivative-
expressed protein 1
46
THBD Endothelial cell receptor 46
p41 ARC Centrosomal homeostasis
(activator and substrate of
Aurora kinase)
47
RUNX3 TGF beta signaling 48
TFF2 Trefoil factor 2, epithelial repair 49
WWOX Putative oxidoreductase, plays a role in
apoptosis
50
COX2 Mediator of inflammation 51
GSTP1 Glutathione S-transferase P1-1 51
RASSF1A Ras association domain family 1A 51
Table 2 Hp-related global epigenetic alterations in gastritis and
gastric cancer
Epigenetic marks Alteration Reference
H3K9me3 Increased levels 53
HDAC1, 2, 3 Overexpression 54
H3S10 phosphorylation Increased levels 55
H3K27me3 Increased levels 56
Global DNA methylation Decreased levels 35
LINE-1 methylation Decreased levels 57
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signaling cascade that may lead to aberrant hypermethy-
lation in gastric cells [65]. Interestingly, cyclosporine A,
which suppresses inflammation without affecting bacterial
colonization, abolished the aberrant methylation of several
genes, indicating that in these cases inflammatory process
mediated gene-specific hypermethylation [66].
However, to reach a more comprehensive view of early
molecular events and epigenetic dynamics associated with
Hp infection, it is critical to identify the specific epigenetic
modifications and alterations directly triggered by Hp in
gastric host cells. In particular, it is important to distinguish
the epigenetic modifications not mediated by inflammatory
molecules produced by other sources within the infected
tissue.
Chromatin modification directly triggered in host cells
by Helicobacter pylori
The exciting recent emerging evidences of bacterial impact
on host epigenetics emphasize a novel strategy used by
bacterial pathogens to interfere with key cellular processes.
Recent illuminating studies demonstrate that bacteria or
bacterial components (e.g., LPS) are able to provoke his-
tone modifications and chromatin remodeling in infected
cells, thereby altering the host’s transcriptional program
[67–71]. The coming era of pathoepigenetics of microbial
infections has been therefore foreseen [72].
Chromatin modifications directly induced by Helico-
bacter pylori have been recently reported (Table 4). One of
the first evidence was obtained by studying IL-6 gene in
macrophages and the signaling cascade that caused chro-
matin changes at IL-6 promoter [67]. IL-6 is overexpressed
in the mucosa at the margin of gastric ulcers and may be
responsible for Hp-induced tissue invasion by macro-
phages. Recently, Pathak et al. [67] identified a Hp factor,
HP0175, responsible for IL-6 gene activation causing gene-
specific histone modifications. The authors showed that
HP0175, a TLR-4 interacting protein [26], induced NF-jB,
ERK and p38 MAPK activation, which in turn activated
IL-6 expression. Furthermore, IL-6 expression correlated
with phosphorylation of H3S10 at the IL-6 promoter. This
modification occurred upon the induction of ERK and p38
that in turn activated MSK1, a serine kinase responsible for
phosphorylating H3S10 [67]. H3S10 phosphorylation was
shown to be required for NF-jB-dependent IL-6 expression
upon TLR4 activation by HP0175. In addition, direct
exposure of gastric epithelial cells to Helicobacter pylori
caused upregulation of p21WAF1 protein expression both
in NCI-N87 cell line and in primary gastric cells [60]. The
increased p21WAF1 expression is associated with release
of HDAC1 from the p21WAF1 promoter and hyperacety-
lation of histone H4 [60].
Ding et al. [73] demonstrated that Helicobacter pylori
provoked a cagPAI-dependent dephosphorylation of his-
tone H3S10 and a slight deacetylation of H3K23 in gastric
epithelial cells, but did not affect seven other specific
histone modifications. Hp-induced H3S10 dephosphoryla-
tion was associated with changes in host gene expression
such as upregulation of c-Jun and downregulation of
hsp70. Feheri et al. [74] demonstrated that Hp-induced
modification of the histone H3 phosphorylation status in
gastric epithelial cells may have an impact not only on
transcriptional regulation but also on cell cycle regulation.
In this work, it was shown that infection of gastric epi-
thelial cell lines with Hp leads to type IV secretion system
Table 3 Gene-specific Hp-
related chromatin modifications
in gastric cancer
Genes Gene function Epigenetics modifications References
HLTF Chromatin-remodeling enzyme H3-H4 hypoacetylation 58
p21(WAF1/CIP1) Cyclin-dependent kinase inhibitor 1 H3 hypoacetylation 59
H4 hyperacetylation 60
SLC5A8 Sodium co-transporter Histone hypoacetylation 61
Table 4 Gene-specific chromatin alterations proven to be directly
provoked by Hp–host cell interaction
Genes Gene function Epigenetic
modifications
Reference
p21(WAF1/
CIP1)
Cyclin-dependent
kinase inhibitor 1
H3 hypoacetylation 59
H4 hyperacetylation 60
HDAC1 release
IL-6 Pro-inflammatory and
anti-inflammatory
cytokine
H3S10
phosphorylation
67
COX-2 Mediator of
inflammation
H3K4me2 increase 70
H3K9me2 decrease
H3K27me3
increase
H3 acetylation
increase
iNOS Inducible nitric oxide
synthase
H3 acetylation
increase
71
H3K4me2 increase
H3K9me decrease
MeCP2 release
c-jun Transcription factor H3S10
dephosphorylation
73
hsp70 Heat shock proteins H3S10
dephosphorylation
73
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(T4SS)-dependent decreases in H3 phosphorylation levels
at serine 10 (pH3Ser10) and threonine 3 (pH3Thr3). At the
same time, Hp caused a strong decrease in the cell division
cycle 25 phosphatase (CDC25C). As a consequence,
mitotic histone H3 kinases (vaccinia-related kinase 1,
VRK1) was not fully activated in infected cells. The
authors found that VRK1 activity was reduced after Hp
infection and that overexpression of VRK1 compensated
for the Hp-induced decrease in pH3Ser10. Increased
phosphorylation of H3Ser10 was IkappaB kinase alpha
(IKKalpha)-dependent and occurred at later time points
after infection. These observations highlighted the impact
of bacterial pathogens on host cell chromatin state and
revealed that this modulation reflects the subversion of key
cellular processes such as cell cycle progression.
Recently, a direct impact of Hp exposure on epigenetic
control of COX-2 gene has been demonstrated [70].
Through TLRs receptors, Hp induces expression of host
inflammatory genes such as TNF-a, which in turn activates
NF-kB, a transcription factor whose target genes include
COX-2 [75, 76]. COX-2 gene dysregulation is believed to
play a critical role in gastric cancerogenesis. Therefore,
COX-2-oriented therapy was proposed and showed prom-
ising anticancer efficacy [77]. Epigenetic status of COX-2
has been associated with clinical outcome of gastric cancer
[78]. In particular, it was shown that COX-2 gene hy-
pomethylation correlates with COX-2 overexpression and
poor prognosis [78]. Moreover, transcriptional activity of
COX-2 gene was associated with increased histone H3 and
H4 acetylation in macrophage and smooth muscle cells
study systems [79, 80]. Pero et al. [70] investigated the
epigenetic changes occurring at the COX-2 locus during
the first 48 h after exposure of human MKN28 gastric cells
to Hp. The expression levels of COX-2 gene increased
dramatically upon Hp stimulation concomitantly with the
occurrence of several chromatin and DNA methylation
changes. It was shown that the main drivers of COX-2
activation upon Hp exposure were the increased levels of
H3K4me2 and the decreased H3K9 methylation state.
Conversely, H3K27me3 levels significantly increased at
COX-2 promoter shortly after Hp exposure, despite the
concomitant detection of the highest COX-2 mRNA levels.
Interestingly, the H3K4me2 and H3K9me2 basal levels
were restored within 24 h, while the higher H3K27me3
levels persisted for longer time after Hp infection. These
phenomena possibly reflected a more refractory state of the
COX-2 gene in cells exposed to Hp compared to unex-
posed cells. The stable repressive mark, H3K27me3, is
associated with the Polycomb repressor complex (PrC).
Because PrC includes DNA methyltransferase activity
[81], it was suggested that high H3K27me3 levels could
increase the susceptibility of COX-2 promoter to altera-
tions in DNA methylation profiles.
More recently, Angrisano et al. [71] described in detail
the specific chromatin dynamics at iNOS gene early after
Hp infection of cultured gastric cells. In this work, the
authors investigated the epigenetic changes occurring at
iNOS locus during the first 48 h after exposure of MKN28
gastric cells to Hp. MKN28 cells expressed low levels of
iNOS mRNA and protein under the unstimulated condition.
The expression levels of iNOS mRNA increased early and
dramatically upon Hp stimulation concomitantly with the
occurrence of several chromatin changes including tran-
sient histone H3 hyperacetylation. Modulation of histone
deacetylase expression in Hp-exposed gastric cells was
previously described in an animal model [82]. Angrisano
et al. [71] also demonstrated that the main epigenetic
drivers of iNOS activation upon Hp exposure were the
increase in H3K4me2 levels and the decrease in H3K9
methylation state. Because LSD1 has both repressive and
activating effects through H3K4 and H3K9 demethylation
capability [83, 84], the Hp-dependent histone modification
occurring in gastric cells pretreated with different LSD1
inhibitors was investigated. LSD1 inhibitors had no effects
on iNOS basal levels, while a strong influence on Hp-
induced iNOS activation was observed [71]. In fact, LSD1
inhibitors repressed Hp-dependent iNOS activation during
the first 4 h after Hp infection; however, they could not
prevent the iNOS induction at later times (6 h). The
authors’ interpretation of these data was that early Hp-
dependent iNOS activation requires LSD1 (or other
monoamineoxidase) activity, while the later iNOS peak
(6 h) may be the result of different putative enzymatic
activity. Interestingly, MeCP2, a methyl-binding protein
frequently associated with a chromatin repressor complex
including HDAC1 and Sin3A [85], was present at iNOS
promoter in non-infected cells and then displaced together
with repressor complex upon infection [71]. The authors
proposed a model in which LSD1, limited to the first
phases of infection, and MeCP2 may play an intermediary
role between repressive and active histone marks by
removing methylation and providing the naked lysine res-
idue to be acetylated [71] (Fig. 1).
DNA methylation changes directly induced
by Helicobacter pylori in host cells
While the mechanisms leading to chromatin changes
induced by Helicobacter pylori have been in some cases
investigated in detail, much less is known about the
molecular events leading to specific changes in DNA
methylation patterns upon Hp infection of gastric cells.
Increased expression of DNA methyltransferases DNMT1
and DNMT3a [50], mediation by PcG complex [56],
injection of bacterial DNA methyltransferases homologs
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[86] or involvement of inflammatory molecules [87, 88] are
some of the mechanisms that have been proposed to date.
However, evidence that altered DNA methylation may be
induced by Hp has been recently reported [49, 50, 70, 87–
90] included those summarized in Table 5. Katayama et al.
[87] using gastric cells co-cultured with macrophages,
focused on a cancer suppression gene, RUNX3, and dem-
onstrated the following: (a) Hp induces nitric oxide (NO)
production in macrophages. (b) NO causes methylation of
RUNX3 in epithelial cells. (c) Hp induces the methylation
of RUNX3 in epithelial cells in the presence of macro-
phages, which is reversed by an NO-specific inhibitor.
These results indicated that Hp-induced RUNX3 methyla-
tion is mediated by NO which in turn is produced by
macrophages in response to Hp exposure.
Hypermethylation of E-cadherin gene is a well-estab-
lished early event in gastric cancerogenesis [38, 39, 44].
Huang et al. [88] indicated that E-cadherin gene
H3K27
me3
No infection H. pylori-infection
NF-kB
IL6
MAPK
IL6
p-MAPK
H3S1
0P
H3S1
0 P
H3S1
0P
NF-kB
COX-2
HDAC
COX-2
H3K27
me3
Cyclic DNA methylation/demethylation
Corepressors LSD1
iNOS
Coactivators
iNOS
LSD1MeCP2 H3Ac
H3K4
me2
Inactive chromatin configuration Active chromatin configuration
H3S1
0
H3S1
0
H3S1
0
MSK1
H3Ac
H3K9
me2
H3
Ac
H3K4
me2
H3K9
me2
H3
Ac
H3K4
me2
H3K9
me2
MeCP2
H3K4
me2
H3K9
me2
H3
Ac
Fig. 1 Schematic models illustrating possible sequence of epigenetic events at IL6, COX-2 and iNOS genes upon Hp-induced activation. See
also text for further explanation and references. MeCP2 Methyl-CpG-binding protein 2, LSD1 lysine-specific demethylase 1
Table 5 Gene-specific DNA methylation alterations proven to be directly provoked by Hp–host cell interaction
Genes Gene function Epigenetics modifications References
TFF2 Epithelial repair DNA hypermethylation 49
WWOX Putative oxidoreductase, plays a role in apoptosis DNA hypermethylation 50
DNMT1 increase
DNMT3b increase
COX-2 Mediator of inflammation Cyclic DNA methylation/demethylation 70
RUNX3 TGF beta signaling DNA hypermethylation (mediated by macrophages) 87
E-cadherin Calcium-dependent adhesion DNA hypermethylation (via IL-1b stimulation) 88
USF1 Transcription factor DNA hypermethylation 89
E-box binding protein
USF2 Transcription factor DNA hypermethylation 89
E-box binding protein
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methylation could be achieved by Hp infection of gastric
cells even in the absence of co-cultured macrophages;
nevertheless, such hypermethylation was mediated by IL-
1b and activation of nitric oxide production in gastric
cancer cell [88]. Increased expression of NFjB was
accompanied by upregulation of iNOS and production of
NO in treated cells. Reversal of all these phenomena in
cells pretreated with IL-1 receptor antagonist suggests a
model in which H. pylori-induced E-cadherin methylation
occurs via IL-1b stimulation of the NFjB transcriptional
system and leads to the activation of DNMT activity by NO
production [88].
Peterson et al. [49] investigated the epigenetic silencing
of Trefoil Factor 2 (TFF2), a tumor suppressor gene, in
gastric biopsy specimens from individuals with Hp-positive
gastritis, intestinal metaplasia, gastric cancer and disease-
free controls and found that DNA methylation at the TFF2
promoter began at the time of Hp infection and increased
throughout gastric tumor progression.
TFF2 methylation levels were inversely correlated with
TFF2 messenger RNA levels, and the authors proposed that
this methylation marker could be used to distinguish
between disease-free controls, Hp-infected and tumor tis-
sues. Genome demethylation restored TFF2 expression in
gastric cancer cell lines, so TFF2 silencing requires DNA
methylation. Moreover, experimental Hp infection in wild-
type mice reduced antral expression of TFF2 by increased
promoter methylation. The authors also concluded that
TFF2 gene product and Hp-related alteration in TFF2 gene
DNA methylation state may play an active role in gastric
cancerogenesis. In fact, TFF2 negatively regulates prene-
oplastic progression and subsequent tumor development in
the stomach, a role that is subverted by promoter methyl-
ation during Hp infection [49].
Upstream stimulatory factors 1 and 2 (USF1 and USF2)
are transcription factors and tumor suppressor genes that
bind E-box of target genes potentially in a competitive
manner with c-myc oncogene product [89, 90]. A decrease
in USF1 and USF2 expression is observed in different
human gastric epithelial cell lines infected with Hp, asso-
ciated with a lower binding to their DNA E-box recogni-
tion site. The treatment of cells with 50-azacytidine, an
inhibitor of DNA methylation, restored the USF1 and
USF2 gene expression in the presence of infection [89]. By
promoter methylation PCR assays, the promoter regions of
both USF1 and USF2 genes were found hypermethylated in
infected cells and in gastric tissues derived from infected
mice [89]. Because these epigenetic alterations were found
in metaplastic lesions, the authors suggested that alteration
in USF1 and USF2 levels may play a role in the tumor
promotion during Hp infection.
Another recent study addressed the role of WW domain-
containing oxidoreductase (WWOX) gene methylation during
Hp-related gastric cancerogenesis [50] since WWOX gene
was reported to be a tumor suppressor gene downregulated in
gastric cancer and hypermethylated in other tumors [91].
The results of this study [50] showed that WWOX hy-
permethylation was frequently detected in gastric cancer,
and also significantly correlated with Helicobacter pylori
infection. WWOX thus behaves as a specific tumor sup-
pressor gene in Hp-related gastric cancerogenesis. Pro-
moter methylation of WWOX, as well as expression of
DNMT1 and DNMT3A, was induced in both BCG823 and
AGS gastric cells co-cultured with Hp a few days after
infection, suggesting a direct role of Hp in determining the
alteration in WWOX gene methylation state.
Pero et al. [70] used mass spectrometry (MALDI-TOF) to
study DNA methylation changes at several CpG sites on both
strands of COX-2 regulatory region. The novelty of this work
was that the methylation analysis was performed by col-
lecting the cells at short intervals of 5 min for a total of
120 min after Hp infection of gastric cells. The results
showed that COX-2 gene activation, as well as most of the
chromatin events occurring at COX-2 gene in response to Hp
exposure, is preceded by rapid strand-specific DNA methy-
lation/demethylation events at 8 specific CpG sites (-176,
-136, ?25, ?36, ?57, ?82, ?198, ?231) surrounding the
COX-2 gene transcriptional start site. DNA methylation has
been considered for long time a simple epigenetic mark
generally associated with transcriptional silent, condensed
chromatin. Only very recently, evidence of an unanticipated
dynamic role of DNA methylation in gene regulation in
human cells has been reported for estrogen-responsive genes
[92, 93]. The mechanisms underlying the methylation/
demethylation cycles at estrogen-responsive genes have
been investigated in-depth and revealed that the demethyl-
ation process is initiated by the same enzymes that establish
the methylation mark, the DNA methyltransferases
DNMT3A and DNMT3B [92, 93]. Thus, it is likely that a
similar phenomenon may be directly initiated at the COX-2
gene promoter upon Hp infection of gastric cells. Because in
MKN28 cells as well as in normal gastric mucosa most of
CpG sites at the COX-2 promoter display about 70 %
methylation degree, the observed transient changes in DNA
methylation could be critical for COX-2 derepression. The
authors propose a model in which the DNA methylation/
demethylation events are triggered by the binding of NF-kB
to the COX-2 promoter, allowing chromatin to reach an open
conformation through modification of histone acetylation
and methylation [70].
Conclusions
There is plenty of experimental evidence showing a cor-
relation between Helicobacter pylori infection, host cell
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epigenetic alterations and gastric cancer. Several of such
alterations could be mediated by the inflammatory process
or can be achieved in late steps of gastric cancerogenesis.
However, the precise nature and sequence of these
molecular events remain largely unknown. Nevertheless, it
is now emerging that the interaction between Helicobacter
pylori and gastric cells may have a direct impact on host
cell epigenetics possibly contributing to initiation of the
cancerogenesis process. The study of microbe-induced
epigenetic alterations in host cells represents a new, rapidly
emerging field of investigation, and the study of the direct
epigenetic effects of Hp infection is going to gain ground.
However, to date, only a few studies have addressed this
topic and a complete map of early epigenetic alterations
and of the underlying molecular mechanisms is far to be
drawn. Possibly, future genome-wide approaches able to
give a comprehensive view of Hp-induced epigenetic
modifications, including the newly discovered 5-hydrox-
ymethylcytosine, could give a great contribution to unravel
the causal role of Hp-induced epigenetic reprogramming. It
is likely that this knowledge may have a critical impact on
future epigenetic-based therapy or prevention strategies for
Hp-related gastric diseases.
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